Bain Capital — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Airside Mobileairsidemobile.comAug 2020acquired by Onfido

Secure digital platform (Mobile Passport) for presenting and authenticating government-issued ID; acquired by Onfido.

Arlington, US

Hans Miller(Executive Officer, Director)Adam Tsao(Director)

Board Robert Poulin(Director)in Julia Taxin(Director)in

Co-investorsBain Capital Ventures Blazar Ventures, LLC Grotech Ventures K Street Capital Moderne Ventures

Featherfeather.solutionsFeb 2020 · $30M

Feather is a cloud-based engineering simulation platform that runs finite element analysis — including linear static, thermal, modal, harmonic, and buckling analysis — for single parts and assemblies.

Cloud ComputingDeep TechSaaS

Co-investorsRoot Ventures Manager, Llc Cobalt Capital Fuel Capital Keen Venture Partners Kleiner Perkins PJC +3 more

Syros Pharmaceuticals, Inc.syros.comDec 2020

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

BiotechCambridge, US

Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)

Co-investorsAisling Capital ARCH Venture Partners Quan Capital Alexandria Ally Bridge Group Bain Capital Life Sciences +11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.